Assembly Biosciences, Inc.
NASDAQ:ASMB
18.17 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 7.163 | 0 | 6.254 | 79.105 | 15.963 | 14.804 | 9.019 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.45 | 0.498 | 0.466 | 0.101 | 0.085 | 72.741 | 44.225 | 0.08 | 0.065 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 6.713 | -0.498 | 5.788 | 79.004 | 15.878 | -57.937 | -35.206 | -0.08 | -0.065 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.937 | 0 | 0.925 | 0.999 | 0.995 | -3.914 | -3.904 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 48.9 | 69.98 | 68.524 | 106.823 | 85.757 | 72.741 | 44.225 | 33.093 | 18.358 | 10.717 | 15.029 | 19.514 | 25.278 | 1.851 | 2.943 | 5.979 |
| General & Administrative Expenses
| 22.909 | 24.134 | 28.78 | 37.058 | 32.919 | 34.798 | 17.021 | 12.185 | 11.298 | 13.24 | 4.576 | 5.341 | 8.724 | 2.916 | 0.397 | 1.186 |
| Selling & Marketing Expenses
| -0.45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 22.459 | 24.134 | 28.78 | 37.058 | 32.919 | 34.798 | 17.021 | 12.185 | 11.298 | 13.24 | 4.576 | 5.341 | 8.724 | 2.916 | 0.397 | 1.186 |
| Other Expenses
| 0 | 0 | 41.638 | 0 | 0.005 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 71.359 | 94.114 | 97.304 | 143.881 | 118.676 | 107.539 | 61.246 | 45.278 | 29.656 | 23.956 | 19.605 | 24.855 | 34.002 | 4.766 | 3.34 | 7.164 |
| Operating Income
| -64.646 | -94.114 | -132.688 | -64.776 | -102.713 | -92.735 | -52.227 | -45.278 | -29.656 | -23.956 | -19.605 | -24.855 | -34.002 | -4.766 | -3.34 | -7.164 |
| Operating Income Ratio
| -9.025 | 0 | -21.217 | -0.819 | -6.434 | -6.264 | -5.791 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 3.451 | 1.022 | 0.302 | 2.624 | 4.305 | 3.083 | -0.615 | -1.14 | -0.027 | 0.168 | 0.201 | 0.065 | -0.302 | -10,524,368 | 0 | 0 |
| Income Before Tax
| -61.195 | -93.092 | -132.386 | -62.152 | -98.408 | -89.652 | -51.859 | -44.879 | -28.454 | -23.789 | -19.404 | -24.79 | -34,344.73 | -15,290,625 | 0 | 0 |
| Income Before Tax Ratio
| -8.543 | 0 | -21.168 | -0.786 | -6.165 | -6.056 | -5.75 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.033 | -1.022 | -2.531 | -2.624 | -0.774 | 1.099 | -9.05 | -0.618 | -1.202 | 0 | 0.201 | 0.065 | 0.343 | -10,524,357.476 | 1.199 | 1.622 |
| Net Income
| -61.228 | -92.07 | -129.855 | -59.528 | -97.634 | -90.751 | -42.809 | -44.262 | -28.454 | -23.789 | -19.404 | -24.79 | -34.345 | -15.291 | -4.539 | -8.786 |
| Net Income Ratio
| -8.548 | 0 | -20.764 | -0.753 | -6.116 | -6.13 | -4.747 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -13.38 | -22.82 | -36 | -20.16 | -44.62 | -3.98 | -2.41 | -2.57 | -1.81 | -3.4 | -5 | -9.74 | -17.86 | -123.33 | -51 | -104.17 |
| EPS Diluted
| -13.38 | -22.82 | -36 | -20.16 | -44.62 | -3.98 | -2.41 | -2.57 | -1.81 | -3.4 | -5 | -9.74 | -17.86 | -123.33 | -51 | -104.17 |
| EBITDA
| -64.196 | -94.114 | -49.412 | -64.085 | -102.713 | -92.092 | -51.393 | -44.058 | -29.564 | -23.945 | -19.398 | -24.786 | -33.696 | -4.754 | -3.333 | -7.16 |
| EBITDA Ratio
| -8.962 | 0 | -7.901 | -0.81 | -6.434 | -6.221 | -5.698 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |